MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
2415.99%
Quick Ratio
2415.99%
Cash Ratio
2067.44%
Debt to Asset Ratio
5.73%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Short-term investments
    • Less accumulated depreciation
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Operating lease liabilities, net...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
301,454
20,955
26,701
25,508
Short-term investments
47,940
65,827
81,307
97,460
Other receivables (including related party amounts of 0 and 61, respectively)
141
-
67
79
Prepaid expenses and other current assets
2,741
1,958
4,591
6,477
Total current assets
352,276
88,740
112,666
129,524
Restricted cash
461
461
461
461
Property and equipment
15,454
15,322
15,075
14,789
Less accumulated depreciation
9,783
9,106
8,457
7,808
Property and equipment, net
5,671
6,216
6,618
6,981
Operating lease right-of-use assets
9,236
9,884
10,525
11,262
Financing lease right-of-use asset
180
196
212
216
Other long-term assets
809
458
458
418
Total assets
368,633
105,955
130,940
148,862
Accounts payable
1,386
2,286
355
848
Accrued expenses (including related party amounts of 22 and 0, respectively)
9,896
5,559
9,600
7,026
Current portion of operating lease liabilities
3,299
3,024
3,015
3,097
Current portion of financing lease liability
-
11
44
75
Other current liabilities
-
-
73
73
Total current liabilities
14,581
10,880
13,087
11,119
Operating lease liabilities, net of current portion
6,550
7,228
7,883
8,519
Total liabilities
21,131
18,108
20,970
19,638
Common stock, 0.0001 par value 700,000,000 shares authorized at june 30, 2026 and december 31, 2025 48,792,279 and 24,595,550 shares issued and outstanding at june 30, 2026 and december 31, 2025 respectively
5
3
3
3
Additional paid-in capital
726,588
441,927
440,413
438,911
Accumulated other comprehensive (loss) income
-21
-18
103
87
Accumulated deficit
-379,070
-354,065
-330,549
-309,777
Total stockholders' equity
347,502
87,847
109,970
129,224
Total liabilities and stockholders' equity
368,633
105,955
130,940
148,862
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$301,454K (958.92%↑ Y/Y)Short-term investments$47,940K (-57.91%↓ Y/Y)Prepaid expenses andother current assets$2,741K (-58.91%↓ Y/Y)Other receivables(including related party...$141K (370.00%↑ Y/Y)Property and equipment$15,454K (10.01%↑ Y/Y)Total current assets$352,276K (136.32%↑ Y/Y)Operating leaseright-of-use assets$9,236K (-27.33%↓ Y/Y)Property and equipment,net$5,671K (-17.64%↓ Y/Y)Other long-termassets$809K (2028.95%↑ Y/Y)Restricted cash$461K (0.00%↑ Y/Y)Financing leaseright-of-use asset$180K (-22.08%↓ Y/Y)Less accumulateddepreciation$9,783K (36.60%↑ Y/Y)Total assets$368,633K (117.62%↑ Y/Y)Total liabilities andstockholders' equity$368,633K (117.62%↑ Y/Y)Total stockholders'equity$347,502K (133.16%↑ Y/Y)Total liabilities$21,131K (3.84%↑ Y/Y)Accumulated deficit-$379,070K (-31.51%↓ Y/Y)Accumulated othercomprehensive (loss) income-$21K (-1150.00%↓ Y/Y)Additional paid-in capital$726,588K (66.16%↑ Y/Y)Total currentliabilities$14,581K (35.41%↑ Y/Y)Operating leaseliabilities, net of current...$6,550K (-31.64%↓ Y/Y)Common stock, 0.0001par value...$5K (66.67%↑ Y/Y)Accrued expenses(including related party...$9,896K (69.51%↑ Y/Y)Current portion ofoperating lease...$3,299K (-6.70%↓ Y/Y)Accounts payable$1,386K (14.07%↑ Y/Y)

Artiva Biotherapeutics, Inc. (ARTV)

Artiva Biotherapeutics, Inc. (ARTV)